To exploit further therapeutically targeting of stabilized MIF, we administered Hsp90 inhibitors to healthy epithelial/mucosal-derived and tumor-derived murine colonic organoids from the same AOM/DSS-induced mice (i.e., matched pairs). This evidence concerns the gene MIF and neoplasm.